Insider Selling: Paul D. Rubin Sells 1,785 Shares of XOMA Corp Stock (XOMA)
XOMA Corp (NASDAQ:XOMA) CMO Paul D. Rubin sold 1,785 shares of XOMA Corp stock on the open market in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $4.22, for a total transaction of $7,532.70. Following the completion of the transaction, the chief marketing officer now directly owns 83,601 shares of the company’s stock, valued at approximately $352,796. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
XOMA Corp (NASDAQ:XOMA) opened at 4.14 on Friday. XOMA Corp has a 1-year low of $3.31 and a 1-year high of $9.57. The stock has a 50-day moving average of $4.07 and a 200-day moving average of $5.84. The company’s market cap is $442.6 million.
XOMA Corp (NASDAQ:XOMA) last issued its quarterly earnings data on Wednesday, May 7th. The company reported ($0.23) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.17) by $0.06. The company had revenue of $3.41 million for the quarter, compared to the consensus estimate of $7.40 million. During the same quarter in the prior year, the company posted ($0.30) earnings per share. The company’s quarterly revenue was down 63.9% on a year-over-year basis. On average, analysts predict that XOMA Corp will post $-0.64 earnings per share for the current fiscal year.
A number of research firms have recently commented on XOMA. Analysts at Wedbush raised their price target on shares of XOMA Corp to $14.00 in a research note on Monday, May 12th. They now have an “outperform” rating on the stock. Separately, analysts at MLV & Co
upgraded shares of XOMA Corp from a “hold” rating to a “buy” rating in a research note on Tuesday, April 29th. They now have a $7.00 price target on the stock. They noted that the move was a valuation call. Finally, analysts at MLV & Co
downgraded shares of XOMA Corp from a “buy” rating to a “hold” rating in a research note on Tuesday, March 11th. They now have a $7.00 price target on the stock, down previously from $8.00. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and six have assigned a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $9.11.
XOMA Corporation (NASDAQ:XOMA) is engaged in the discovery and development of antibody-based therapeutics.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.